Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 9, 2026 · Filed Nov 12, 2026
An Amdocs director paid $150K out of pocket for Amdocs shares. 4 other people at Amdocs bought some too, in the same month. Shares held went up 31% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$149,730
Shares × reported transaction price
$100K–$500K
+31.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
5 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $41.74 on Nov 9, 2026, at its 52-week low, after a 27% drop over the previous 30 trading days
52-week range $41.74 (Nov 9, 2026) to $85.49 (Nov 10, 2025), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $57.42 on Sep 28, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Hortig Shimie (Officer) plans to sell ~$303K of Amdocs
Planned, from payHortig Shimie (Officer) plans to sell ~$72K of Amdocs
Planned, from payEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.